In turn, the brain is the second major site of dystrophin gene expression, and cognitive and behavioral impairments associated with DMD add to the very severe burden of this disease, affecting the quality of life of patients and their families. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.